Li-Kuei Chen

Dr. Li-Kuei Chen

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
HHHsing-Wen Hsu
Hsing-Wen Hsu
YCYa-Jung Cheng
Ya-Jung Cheng
LCLi-Kuei Chen
Li-Kuei Chen
YWYong-Ping Wang
Yong-Ping Wang
CLChen-Jung Lin
Chen-Jung Lin
WSWei-Zen Sun
Wei-Zen Sun
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to enhance opioid analgesia in the acute pain service. The question, however, of whether NSAIDs produce a similar extent of potentiation among different types of pain, has not been thoroughly investigated. A randomized, placebo-controlled, double-blind study was performed to characterize the analgesic effect of tenoxicam, a long-acting NSAID, on resting wound pain, evoked wound pain, and uterine cramping pain after cesarean section. Saline (n = 48) or 20 mg tenoxicam (n = 45) was intravenously injected immediately after clamping the umbilical cord. All patients were instructed to obtain maximal postoperative analgesia by intravenous patient-controlled morphine. Tenoxicam profoundly reduced the intensity of uterine cramping pain (3.6 [2.0–5.6] versus 5.5 [3.4–6.6];p < 0.01) but had no additional effect on wound pain at rest, with movement, changing position, sitting, and walking. Intraoperative injection of 20 mg tenoxicam decreased the demand ratio for patient-controlled analgesia (PCA) and 24-hour morphine consumption by approximately 30%. The data show that tenoxicam potentiates opioid analgesic effect on the somatic and visceral types of pain to different extents, and they suggest that intraoperative injection of 20 mg tenoxicam is sufficient to enhance intravenous PCA morphine on uterine cramping pain for the first 24 hours after cesarean section.

5 January 2011 in Urologia Internationalis
Verified
Journal Article
Closed access
SCSaint Shiou-Sheng Chen
Saint Shiou-Sheng Chen
LCLi-Kuei Chen
Li-Kuei Chen
Aim: To examine the predictive factors of successful varicocelectomy in infertile patients. Methods: Thirty-five infertile male patients with varicocele and requiring varicocelectomy were recruited in this study. The patients were divided into 2 groups based on their recovery outcome after subinguinal microsurgical varicocelectomy. Patients who showed significant improvement on their sperm density, motility and morphology 6 months after varicocelectomy were designated as group 1, whereas those who showed no improvement 6 months after surgery were designated as group 2. The predictive factors that were examined included: age; preoperative semen quality (i.e. sperm density, motility and morphology); testicular volume; seminal volume; varicocele grade; the number of ligated veins; body mass index (BMI), and serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, testosterone, alkaline phosphatase (Alk-p), lactic dehydrogenase (LDH), cholesterol and triglyceride. Results: Sperm density, motility and morphology improved significantly 6 months after varicocelectomy in group 1 patients (n = 35; 71.4%). Group 1 patients had significantly higher testicular volumes (mean ± SD: 29.6 ± 5.9 vs. 23.2 ± 6.1 ml), lower FSH (11.3 ± 2.9 vs. 16.1 ± 4.8 mIU/ml) and higher numbers of ligated veins (9.3 ± 0.8 vs. 7.9 ± 0.7) than group 2 patients. No significant association was observed between surgical outcome and age, preoperative sperm density, motility and morphology, seminal volume, varicocele grade, BMI and serum levels of LH, prolactin, testosterone, Alk-p, LDH, cholesterol and triglyceride. Conclusions: These findings suggest that the significant predictive factors of successful varicocelectomy in infertile patients were high testicular volume (>29.6 ml), low serum concentration of FSH (9).

17 January 2012 in Health Policy and Planning
Verified
Journal Article
Open access
PDF file
SWShi-Yi Wang
Shi-Yi Wang
LCLi-Kuei Chen
Li-Kuei Chen
SHSylvia H Hsu
Sylvia H Hsu
SWShih-Chieh Wang
Shih-Chieh Wang
Facing escalating health care expenditures, the governments of countries with national health insurance programs are trying to control or even to reduce health care utilization. Little research has examined the effects of decreased health care utilization on health outcomes. Applying a natural experiment design to the Taiwan population between 2000 and 2004, which includes the 2003 SARS epidemic when an average 20% decline in health care utilization occurred, this study examines the association between a decline in health care utilization and health outcomes measured by cause-specific mortality rates. We analyse the monthly mortality rates caused by infectious diseases, cancer, diabetes mellitus, nervous system diseases, cerebrovascular diseases, heart and other vascular diseases, respiratory system diseases, digestive system diseases, genitourinary system diseases and accidents. Models control for age, sex, month and year effects. Results show the heterogeneous effect of reduced health care utilization on health outcomes. Patients with diabetes mellitus or cerebrovascular diseases are vulnerable to short-term reductions in health care; compared with the non-SARS period, mortality caused by diabetes mellitus and cerebrovascular diseases significantly increased during the SARS epidemic by 8.4% and 6.2%, respectively. No significant change in mortality rates caused by the other diseases or accidents is found. This study suggests that governments of countries where health care utilization and spending are similar to or inferior to those in Taiwan should carefully evaluate the impact of policies that attempt to reduce health care utilization. Furthermore, when an area encounters an epidemic, governments should be aware of the negative consequences of voluntary restraints on access to health care that accompany decreases in utilization.

23 December 2004 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
SPS. S. Peng
S. S. Peng
WHW. C. Hsu
W. C. Hsu
HCH. C. Chou
H. C. Chou
LCLi-Kuei Chen
Li-Kuei Chen
YCY. L. Chang
Y. L. Chang
FHF. J. Hsieh
F. J. Hsieh


1 March 2001 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
HYHuei-Ming Yeh
Huei-Ming Yeh
LCLi-Kuei Chen
Li-Kuei Chen
MSMing-Kwang Shyu
Ming-Kwang Shyu
CLChen-Jung Lin
Chen-Jung Lin
WSWei-Zen Sun
Wei-Zen Sun
STShen-Kou Tsai
Shen-Kou Tsai
The combination intrathecal fentanyl (25 μg) and bupivacaine (2.5 mg) provides effective labor analgesia for approximately 90 minutes. The purpose of this prospective, randomized, double-blinded investigation was to determine if the addition of morphine (150 μg) to the intrathecal combination of fentanyl (25 μg) and bupivacaine (2.5 mg) would prolong labor analgesia. By using the combined spinal epidural technique, 95 healthy primiparous laboring women in early labor received 2 mL of one of the two intrathecal study solutions, either FB (n = 48): fentanyl (25 μg) and bupivacaine (2.5 mg); or FBM (n = 47): fentanyl (25 μg) and bupivacaine (2.5 mg) plus morphine (150 μg). The mean duration of labor analgesia was significantly longer in the FBM group than in the FB group (252 ± 63 min vs 148 ± 44 min, P < 0.01). There were no significant differences between the two groups regarding the sensory levels, the incidence of nausea, vomiting, pruritus, hypotension, or operative delivery. In conclusion, the addition of 150 μg of morphine to the intrathecal combination of fentanyl plus bupivacaine prolonged the duration of labor analgesia duration without increasing adverse effects.